Table 4.
Comparison of ADC values between benign and malignant lesions stratified by background parenchymal enhancement (BPE), amount of fibroglandular tissue (FGT) and menopausal status
| Variable | Benign lesions | Malignant lesions | p-value* | ||||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| N | ADC value (10−3 mm2/s) | N | ADC value (10−3 mm2/s) | ||||
|
|
|
||||||
| Mean | SD | Mean | SD | ||||
| Overall lesions | 130 | 1.529 | 0.262 | 218 | 1.072 | 0.213 | <0.0001 |
| Background parenchymal enhancement | |||||||
| Low BPE | 65 | 1.585 | 0.305 | 105 | 1.098 | 0.239 | <0.0001 |
| High BPE | 65 | 1.472 | 0.199 | 113 | 1.048 | 0.190 | <0.0001 |
| Amount of fibroglandular tissue | |||||||
| Non-dense breast | 20 | 1.401 | 0.197 | 47 | 1.067 | 0.228 | <0.0001 |
| Dense breast | 110 | 1.552 | 0.267 | 171 | 1.073 | 0.295 | 0.0003 |
| Menopausal status | |||||||
| Premenopausal | 70 | 1.541 | 0.256 | 124 | 1.044 | 0.211 | <0.0001 |
| Postmenopausal | 60 | 1.515 | 0.272 | 94 | 1.108 | 0.212 | <0.0001 |
ADC apparent diffusion coefficient, BPE background parenchymal enhancement, FGT fibroglandular tissue, SD standard deviation
Of comparison between benign and malignant lesions